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Summary: Cholesterol was assayed on the Greiner GSA II and the Technicon SMA 12/60 and SMA II auto-
analyzers, vnthAllairfs entirely enzymic method (Allain et al. (1974), Clin. Chem. 20,470-475). The coefficients
of variation in the results over a period of one month were less than 6% with the GSA II and the SMA II, but up to
9% on the SMA 12/60. Although the accuracy of the enzymic method depends on the specificity of the cholesterol
oxidase and cholesterol esterase, the results were in good agreement with those obtained byAbelPs method (Abell
et al. (1952), J. Biol. Chem. 195, 357-366) on fresh or freeze dried human plasma. The cholesterol concentration
was stable at 4 °C, or in frozen or freeze dried plasma. None of the drugs tested interfered with the enzymic assay.
Enzymatische Bestimmungvon Cholesterin im Plasma: Vergleich analytischer Abweichungen, beobachtet beim
Einsatz des Greiner GSA II und des Technicon SMA 12/60 sowie SMA II
Zusammenfassung: Cholesterin wurde am Greiner GSA II und den Technicon SMA 12/60 und SMA II Auto-
analyzern mit der vollenzymatischen Methode von Allain et al. ((1974), Clin. Chem. 20, 470—475) bestimmt. Die
Variationskoeffizienten der ber einen Zeitraum von einem Monat erhaltenen Ergebnisse waren < 6% mit dem
GSA II und dem SMA II, aber bis zu 9% mit dem SMA 12/60. Obwohl die Richtigkeit der enzymatischen Methode
von der Spezifit t der Cholesterinoxidase und -esterase abh ngt, stimmen die Ergebnisse gut mit denen berein, die
mit der Methode von Abell et al. ((1952), J. Biol. Chem. 795, 357-366) an frischem oder lyophilisiertem Plasma
von Menschen erhalten wurden. Die Cholestefinkonzentration war bei 4 °C oder in gefrorenem oder lyophilisiertem
Plasma stabil. Keine der gepr ften Pharmaka st rten den enzymatischen Test.
Introduction SMA II use continuous flow. Beside control for precision
_ , j ο , , , and linearity, the accuracy and specificity of the meas-
Enzymic methods for assaying cholesterol are based on ^^ ^
 with the three apparatuses have been
the measurement of the hydrogen peroxide formed ^.^
 rison with those obtained by the
when cholesterol esters are hydrolyzed by cholesterol ^^
 chemica, method of Abel, et a, (13) In addi.
esterase and the cholesterol thu<s liberated is oxidized
 tfon we ^  made tests on ΑθΓί.ίβπη and iong.term
by cholesterol pxjdase. Various colorimetric reactions ^
 (at + 4 °c and - 196 °C, respectively) of plasma
have been used in these assays (1). Trinder's reaction cholesterol. The results are discussed with regard to the
is now the most commonly used; it was applied to difficulties resulting from the lack of a primary
cholesterol assays by Allain et al. (2) and adapted to
 choiesterol standard for enzymic assay of cholesterol,
many autoanalyzers — continuous-flow (3,4, 5),
centrifugal (6,7, 8), the Vickers (9,10,11), and the
Greiner GSA II (12). Materials and Methods
Here we report results obtained in our laboratory with Method of A bell et al (13)
three apparatuses for cholesterol assay, using the method ^ ,^
 esters were aponified with a,coholic potassium
of Allain et al. One apparatus, the Greiner GSA U, uses hydroxide. Cholesterol was extracted with petroleum ether,
discrete analysis, and the Technicon SMA 12/60 and then assayed by means of the Liebermann-Burchard reaction
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Tab. 1. Final reagent concentration used for enzymic cholesterol assays on three automated analyzers.
Phosphate buffer pH 7.2
Methanol
4 aminophenazone
Hydroxypolyethoxydodecane
Phenol
Cholesterol esterase
Cholesterol oxidase
Peroxidase
GSA II Greiner
360 mmol/1
900 mmol/1
3.36 mmol/1
3.6 g/1
6 mmol/1
> 153 U/l
> 363 U/l
> 2250 U/l
SMA 12/60 Technicon
400 mmol/1
1000 mmol/1
3.5 mmol/1
4 g/1
6.4 mmol/1
>180 U/l
>200 U/l
> 2500 U/l
SMA U Technicon
110
350
0.96
1.1
1.9
>40
>S5
>665
mmol/1
mmol/1
mmol/1
g/1
mmol/1
U/l
U/l
U/l
after evaporation of the solvent. The reagents were prepared
in our laboratory. The calibration curve was obtained from
cholesterol (product No. 26740 puriss from Fluka) dissolved
in ethanoL The technique used was entirely manual, and the
intensity of the coloration was read from a Beckman DB-GT
spectrophotometer.
Enzymic method /
Reagents
For the Greiner GSA II and the Technicon SMA 12/60, we
used a reagent kit (Boehringer, ref. 148 393). The final reagent
concentrations are given in table 1. The composition of reaction
mixture 2, used to measure the serum blank on the Greiner
GSA II, was identical to that used for the assay (mixture 1)
except for the cholesterol oxidase which was omitted. The
concentrations were similar in the two apparatuses. However,
cholesterol oxidase activity was twice as high in the reaction
mixture used in the Greiner GSA II; this mixture was prepared
12 to 15 h before use, in accordance with the recommendations
of Van Gent et al. (14) and Borner et al. (12).
In the Technicon SMA II, the Technicon reagents were used at
the final concentrations shown in table 1.
Technique
For the Greiner GSA II, the analytical procedure followed was
that recommended in technical leaflet 74-3F-1/03/76 (tab. 2).
A sample blank was run in parallel for each assay. The ratio of
sample volume to final volume was 1 to 161. The absorbance
of the assay was read at 546 nm and the absorbance of the
blank was subtracted from that of the assay. The corrected
absorbance is reported as A.
where e = molar absorption coefficient
FV (final volume) = 1610 μΐ
SV (sample volume) * 10 μΐ
1 FVL χ ILL = κ (the multiplication coefficient)
e SV
For the Technicon SMA 12/60, we followed the manufacturer's
instructions. Unlike the Greiner GSA II, it does not require the
use of a reagent blank. The ratio of sample volume to final
volume was 1 to 280. The absorbance was read at 546 nm.
For the Technicon SMA II, the assay procedure recommended
by the manufacturer was not changed.
Results and Discussion
Incubation time
We verified that the time necessary for color develop-
ment at 37 °C was 4 minutes. The incubation times
were 8 min 40 s with the Greiner GSA II, 5 min 20 s
with the Technicon SMA II, and only 50 s with the
Technicon SMA 12/60. In the continuous-flow apparatus,
however, the sample is already in contact with the
reagents before it enters the water-bath. The absorbance
was read at the reaction plateau only with the GSA II
and the SMA II.
Tab. 2. Experimental protocol for cholesterol assay on the
GSA II Greiner.
Plasma
Distilled water
Reaction mixture 1
Reaction mixture 2
Final volume
Volumes
Blank
(Ml)
10
100
1500
1610
Assay
(Ml)
10
100
1500
1610
Incubation
time
(min; s)
8; 40
8; 06
» .
Calculation
The molar concentration of cholesterol was calculated according
to the formula:
1 FV
Calibration
The calibration of an apparatus for enzymic cholesterol
assay poses the particular problem that there are at
present no aqueous primary solutions of cholesterol.
The Greiner GSA II is calibrated by displaying a
coefficient K, which can be calculated from the molar
absorption coefficient of the chromogen formed from
the reaction of hydrogen peroxide with the phenol/4-
aminophenazone pair.
The value for the multiplication coefficient was 46.85
when we used a solution of hydrogen peroxide. When
hydrogen peroxide dilutions were replaced by human
sera calibrated by AbelFs method, the multiplication
coefficient was 38.02, which was the value used for
calibration.
The SMA 12/60 and the SMA II were also calibrated
with commercial titrated human sera.
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Repeatability and reproducibility
The repeatability was evaluated by duplicate assays of
plasma from the patients. The coefficient of variation
was less than 1.5% for the GSA II and 2.8% for the
SMA 12/60 and the SMAII (tab. 3).
Tab. 3. Repeatability of cholesterol assay on three automated
analyzers (Results are expressed in mmol/1).
GSA II
Greiner
SMA 12/60 SMA II
Number of pairs
Mean and variance
Sample 1
30
Sample 2
Coefficient of variation % 1.5
5.87
(0.87)
5.89
(0.83)
64
6.25
(0.61)
6.27
(0.61)
2.8
41
4.62
(1.12)
4.59
(L15)
2.7
The reproducibility was calculated from an untitrated,
freeze-dried serum assayed several times a day. The
results are given in table 4. The variation coefficient
was 2.3 to 6.6% (depending on the month) with the
GSA II, 9% with the SMA 12/60, and 5 % with the
SMA II. The reproducibility ofAbelfs chemical method
was 3.7% within one day and 6.8% from day to day.
Linearity
Linearity was measured from increasing dilutions of
hyperlipemic plasmas and verified up to concentrations
of 13 mmol/1 on the GSA II and up to 10 mmol/1 on
the SMA II. The SMA 12/60 gave a linear response only
from 3.6 mmol/1 up to 10 mmol/1.
Accuracy
The accuracy of the results was assessed by intralabora-
tory and interlaboratory quality controls.
Intralaboratory control
Cholesterol was assayed in fresh human plasma samples
simultaneously on the three apparatuses, and according
to Abeirs method, which is considered the selected
method. The results, compared with those obtained by
the chemical method, are given in table 5.
There is an overestimation of 3% in the results obtained
with the GSA II, 6.5% with the SMA 12/60, and 4%
with the SMA II. The variation in each case is within
the limits of the method's reproducibility. The correla-
tion coefficients bet ween Abell's method and the auto-
mated enzymic methods were 0.91 and 0.97. The disper-
sion of the results was greater with the SMA 12/60
than with the chemical method, the respective standard
deviations being 2.68 and 2.33 mmol/1. In the case of
freeze-dried commercial sera, the results obtained with
the chemical and the enzymic methods agreed (tab. 6).
Tab. 4. Reproducibility of cholesterol assays on three automated analyzers (Results are expressed in mmol/1).
GSA II Greiner
Number
Mean
Standard deviation
Coefficient of variation %
March
43
3.31
0.08
2.3
April
25
3.31
0.18
5.5
May
47
3.13
0.21
6.6
SMA 12/60 Technicon
March
217
3.33
0.30
9
April
180
3.26
0.18
5.5
May
197
3.26
0.15
4.6
SMA II
Technicon
July
214
3.74
0.18
4.9
Tab. 5. Accuracy of cholesterol assay in fresh human plasma by chemical and automated enzymic methods (Results are expressed in
mmol/1).
Abeirs method (xj)
Enzymic method
GSA Ii Greiner ( y t )
Abeirs method (x2)
Enzymic method
SMA 12/60 (y2)
AbeWs method (x3)
Enzymic method
SMA II (y3)
Number of Mean (m) Correlation Regression curve
determinations Standard coefficient
deviation (s)
m = 5.84
N =35 m = 6*03 °·97 yi = 0.98 xj +0.31
s =2.46
m = 5.68
N = 44
 m=6io5 0'95 y2 = 1.18 x2 +0.18
s =2.68
m = 5.75
N =;40
 m "5.51 °·91 y3 = 0.86x3 + 0.57
s = 1.04
Difference
between enzymic
method and
AbeWs method
+ 3.2%
+ 6.5%
+ 4.7%
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Tab. 6. Accuracy: Quality control within the laboratory (Results
are expressed in mmol/1).
Serum 1
Number of samples
Mean
Standard deviation
AbelPs Enzymic method
method
GSA II SMA SMA II
Greiner 12/60 Techni-
Techni- con
con
23 81 209
3.28 3.40 3.19 -
0.23 0.15 0.14 -
Serum 2
Number of samples 11 14
Mean 3.66 3.79
Standard deviation 0.24 0.13
6
3.67
Munster et al. (15) also found that Abel?s method and
the enzymic method gave the same results.
Interlaboratory control
Abell's method remains the method of choice for
cholesterol assay used by the two groups who specialize
in quality control in lipid assays, the World Health
Organization (WHO, Lipid Reference Center for
Europe, Dr. Grafnetter, Prague) and the Center for
Disease Control (CDC, Lipid Research Clinic Labora-
tories, Atlanta).
Our results obtained by means of the enzymic method
adapted to the GSA II were within the 5% limits set by ·
the two control centers (tab. 7).
Tab. 7. Accuracy and precision: interlaboratory quality control
(Results are expressed in mmol/1).
Accuracy Precision
WHO
sera
1
2
CDC
sera
1
2
3
Acceptable
mean
m ± 5 %
3.28 ± 0.16
8.61 ± 0.43
3.23 ± 0.18
6.95 ± 0.33
8.29 ± 0.41
Mean
found
n = 7
3.44
8.86
3.36
6.95
8.50
Acceptable Standard
standard deviation
deviation found
0.18
0.23
0.18
0.21
0.23
0.09
0.10
0.11
0.28
0.14
The specificity of the enzymic method depends upon
that of the cholesterol oxidase (16,17) extracted from
Nocardia erythropolis. This enzyme has a wide spec-
trum: it also partially oxidises Δ 7-cholestanol (15,16,
17,18), and fully oxidises cholestanol arid 7-dehydro-
cholesterol (15). In human plasma these structural
analogues of cholesterol are present at an average level
of 0.05 mmol/1 (20 mg/1) for Δ 7-cholestanol,
0.10 mmol/1 (40 mg/1) for cholestanol, and 0.52 mmol/1
(200 mg/1) for 7-dehydroeholesterol. Therefore, the
values found for an actual cholesterol level of
5.17 mmol/1 (2 g/1) reached 5.94 mmol/1 (2.30 g/1) for
bothAbelFs and the enzymic method.
Furthermore, the kinetics of hydrolysis by cholesterol-
esterase varies with the ester used (15). Cholesterol
acetate, which is put into certain commercial sera, is
hydrolyzed slowly; when such sera are analyzed by
Abell's method, the results are 30% higher than those
obtained by enzymic assay (19.20). Therefore, some
of the commercial freeze-dried sera are apparently not
suitable for calibration or quality control of enzymic
cholesterol assays (21, 22).
BothAbeirs and enzymic methods remain only selected
procedures compared with gas-liquid chrom tography,
which is becoming the reference method. Some studies
have already demonstrated its greater specificity. Among
the numerous derivatives of cholesterol, only cholestanol
has the same retention time as cholesterol, and it is
therefore the only plasma constituent that interferes
in this method (15-23).
Specificity
The possible interferences were tested by treating a pool
of plasma with drugs and bilirubin in solution, each
assay being paralleled with an untreated reference
sample. The results in table 8 are the means of three
measurements made on treated and control plasma
samples with the Greiner GSA II: none of the substances
tested interfered with the enzymic assay.
Tab. 8. Effect of several drugs and of bilirubin on the enzymic
assay of cholesterol on the Greiner GSA II.
Concentration Variation
in treated compared
plasma with control
(mmol/1) (%)
Ascorbic acid
Acetyl salicylic acid
Clofibrate
Rrocetofen
Phenobarbital sodium
Bilirubin
0.11
1.1
12
1
. 2.3
7.3
0.8
34
85
171
-1.4
-0.3
+ 0.5
+ 1.2
+ 0.9
+ 0.5
-2
+ 1.1
-4.3
-0.5
Borner et al. (12) reported a negative interference of
high concentrations (above 0.30 mmol/1) of ascorbic
acid on the enzymic assay of cholesterol, with 1 mmol/1
of ascorbic acid inducing an underestimation of
cholesterol of 0.84 mmol/1. The following substances
do not Interfere with the assay: novalgine (12)>
salicylates, nicotinic acid, phenobarbital (24), steroid
drugs, and hemoglobin (7); nor, even at concentrations
ten times higher than physiological, do uric acid,
J. Clin. Chem. Clin. Biochem, / Vol. 17,1979 / No. 8
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creatinine, urea, and glucose (2,3). However, bilirubin
influences enzymic assays because it absorbs at the
wavelength used in the eolorimetric reaction, and it
reacts with hydrogen peroxide to yield biliverdin. Its
presence in large amounts causes a major underestima-
tion of cholesterol (19). On the GSA II, this error is
avoided by assaying a serum blank (12).
Results in serum and plasma
We have recently demonstrated that there is no signifi-
cant difference between the concentration of cholesterol
in serum and that in heparinized plasma (25). EDTA,
however, has a diluting effect and thereby causes an
osmotic redistribution of water between the cells and
plasma; in its presence, the concentration of the
cholesterol is lower than in serum (26).
Storage
We assessed the effect of the method of storage on the
cholesterol concentration. Three pools of fresh plasma
containing various concentrations of cholesterol were
stored at 4 °C for 5 days and were assayed three times
a day; the variations in the cholesterol concentration
were within the analytical limits and were not
statistically significant (tab. 9). With frozen plasma, our
studies showed that the cholesterol concentration was
stable for a year both at - 30 °C and - 196 °C, as well
as after freeze-drying (27).
Tab. 9. Sera stored five days at 4 °C. Analysis of variance
(F test) of cholesterol assay results on GSA II Greiner
(Results are expressed in mmol/1).
Day
1
2
3
4
5
F
Test
Pooll
Mean
3.04
3.16
3.16
3.19
3.20
3.90
Variance
0.0025
0.0046
0.0025
0.0003
0.0006
ns
Pool 2
Mean
5.59
5.58
5.73
5.80
5.73
2.34
Variance
0.0010
0.0121
0.0146
0.0170
0.0006
ns
Pool 3
Mean
7.67
7.72
7.70
7.88
7.80
1.51
Variance
0.0001
0.0320
0.0085
0.0034
0.0041
ns
Conclusion
We have compared the results from Allain's method of
enzymic cholesterol assay adapted to three different
automated analyzers. The precisions were satisfactory,
especially on the GSA II and SMA II. On the SMA
12/60, the reaction time was too short to allow the
plateau of the reaction to be reached. The results
obtained by the three methods were similar to those
obtained byAbeWs selected method. However, the
accuracy of the enzymic methods depends on the
specificity of both the cholesterol esterase and the
cholesterol oxidase. We found no interference from
the addition of certain drugs or of bilirubin.
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